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syndrome (HIV/AIDS) is one of the most devastating disease 
posing therapeutic and prevention challenges, especially in 
developing countries where it accounts for high morbidity 
and mortality.[1,2] HIV infection in pregnancy has become one 
of the medical complications of pregnancy in the developing 
countries where over 70% of the 35 million people living with 
HIV reside.[1-4] In developed countries profoundly low HIV 
seroprevalence has been reported among pregnant women 
tested before 34 weeks[5] whereas, in developing African 
countries the rates are high ranging from 5.2% to 11.1%.[3,4,6-8] 
In Tanzania, HIV seroprevalence among adults aged between 
15 and 49 years basing on household surveys was found to 
be 5.7%, with the majority of these being women (56%). 
Furthermore, the prevalence of HIV among women attending 
antenatal care (ANC) clinics was 6.8% accounting for 
approximately 100,000 HIV-exposed infants annually.[9,10]
Being sexually active in the midst of undue behavioral drives, 
physiological and biological changes, pregnant women 
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Abstract
Background: Routine testing for human immunodeficiency virus (HIV) among pregnant 
women is done early during antenatal care (ANC) in Tanzania, but retesting for the women 
found negative is rarely done at term or during delivery. Aim: This study aimed at determining 
the magnitude and risk factors associated with HIV seroconversion among pregnant women 
delivering at Bugando Medical Center (BMC). Subjects and Methods: This cross‑sectional 
study was conducted from January to March 2013 involving 400 pregnant women who tested 
HIV negative during ANC. These were re‑tested during delivery, and those found positive (and 
their babies) were given antiretroviral therapy (ART) prophylaxis. All exposed babies were 
tested by polymerase chain reactions (DNAPCR) at 1 month of age. Sociodemographic and 
clinical characteristics were collected using a structured questionnaire and patients’ files. Data 
were analyzed using SPSS version 17.0 software. Results: Of 400 pregnant women (mean 
age 26.4 [5.73] years) enrolled, HIV seroconversion was found in 5.3% (21/400). Upon 
multivariate logistic regression analysis, polygamous marriage (P < 0.001) and history of 
syphilis during ANC visit (P < 0.001) were found to be independent predictors of HIV 
seroconversion among pregnant women delivering at BMC. One of the 21 babies (4.8%) born 
of HIV seroconverted women was confirmed to be HIV infected. Conclusion: The high rate 
of HIV seroconversion found in this study implies that HIV re‑testing should be an enduring 
exercise. This will allow timely provision of ART prophylaxis to HIV seroconverted women 
and their exposed babies and thus, prevent mother to child transmission of HIV.
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continue to be at risk of getting HIV infection as well as posing 
a threat of transmitting HIV to the newborn in utero, during 
delivery or postdelivery through breast feeding.[11-14] Limited 
studies have evaluated HIV seroconversion among pregnant 
women in developing countries and the rates were shown to 
vary	significantly	ranging	from	2.6%	(53/2035)	in	Kenya	to	
17.7% (66/372) in Zimbabwe.[12,15] Despite these variations, 
HIV seroconversion among pregnant women in Tanzania 
remains to be explored because re-testing for the women 
found negative early in the ANC is rarely done at term or 
during delivery. Therefore, this study aimed at determining the 
prevalence of HIV seroconversion among pregnant women and 
its associated risk factors as well as assessing the magnitude 
of mother to child transmission of HIV at Bugando Medical 
Center (BMC).
Subjects and Methods
Study design and sampling process
This cross-sectional hospital-based study was conducted from 
January to March 2013 in the labor ward of BMC. BMC is a 
consultant, referral, and teaching hospital serving a catchment 
area of approximately 13 million people with an average 
of 600 deliveries/month. The study enrolled consecutively 
400 pregnant women coming for delivery at BMC who 
tested HIV negative during ANC visits at least 3 month prior 
to the study period. Pregnant women with unknown HIV 
serostatus on ANC card and those with no ANC card on 
admission as well as those who were in the active phase of 
labor were excluded from the study.
Data collection and laboratory procedures
All eligible pregnant women were identified during the 
admission in the labor ward, the principle investigator 
explained thoroughly the aim of the study and then a written 
informed consent was sought from each study participant. 
Social, demographic, and clinical data were collected using 
a	 structured	 questionnaire,	ANC	 card	 and	 patients’	 files.	
The syphilis screening among pregnant women in the ANC 
in Tanzania is based on the Venereal Disease Research 
Laboratory	test	whereas	the	confirmatory	test	is	based	on	the	
treponemal pallidum hemagglutination test. Provider initiated 
counseling and testing for HIV was conducted basing on the 
new Tanzania algorithm for HIV testing using Determine 
HIV1/2	(Alere	Medical	Company,	Japan)	as	first	test	followed	
by Unigold (Trinity Biotech. Bray. Ireland).[9] All HIV exposed 
babies were tested for HIV at 1 month of age using DNA-PCR 
test.[9,16]
Data analysis
Social, demographic, and clinical data were entered into 
Microsoft excel® (Microsoft Corporation, Washington, U.S) 
for consistent checks and data cleaning and then exported 
into SPSS version 17.0 software® (IBM Corporation, 
NewYork, U.S) for analysis. Continuous data were described 
as mean (standard deviation) or median (interquartile range) 
depending on the distribution of data. Categorical variables 
were reported as a proportion and were compared using 
Chi-squared test or Fischer’s exact test where appropriate. At 
95%	confidence	interval, P ≤	0.05	was	considered	as	significant	
for various predictor variables of HIV seroconversion among 
pregnant women. All predictor variables with association 
on bivariate analysis were subjected to multivariate logistic 
regression analysis.
Study clearance and ethical considerations
This study got ethical clearance from the Catholic 
University of Health and Allied Sciences/BMC Research 
Ethics Committee (CREC/005/001/2013). A written 
informed consent was sought from every participant. 
Provider initiated pre- and post-test counseling for HIV 
was done by the principal investigator and two research 
assistants	(two	trained	nurses).	Unique	study	identification	
numbers were used to ensure anonymity of the study 
participants. HIV infected women and their exposed babies 
were given antiretroviral prophylaxis as per Tanzanian 
National AIDS Control Program (NACP) guidelines[9] 
and then referred care and treatment clinic for further 
management.
Results
Social demographic characteristics of the study 
participants
A total of 2058 pregnant women delivered at BMC during the study 
period, of these 400 were eligible and thus, recruited. The mean 
age of the study participants was 26.4 (5.73), minimum 15 and 
maximum 42 years. More than three quarters of the study 
participants were from the urban area (87.5% [350/400]) and 
married (90.7% [363/400]). About half of the study participants 
were unemployed (49.5% [198/400]) and 42.7% (171/400) 
booked at 4 months of gestation age [Table 1].
Human immunodeficiency virus seroconversion and 
associated risk factors
Human immunodeficiency virus seroconversion was 
found in about 5.3% (21/400) of pregnant women. 
Unmarried women (P = 0.02), women in a polygamous 
marriage (P < 0.001), women living in a separate house 
from husbands (P = 0.02), women married to frequently 
traveling (mobile) husbands (P < 0.001) and those with 
a history of syphilis during ANC visit (P < 0.001) were 
significantly	associated	with	HIV	seroconversion	on	bivariate	
analysis. Upon multivariate logistic regression analysis, 
polygamous marriage (P < 0.001) and history of syphilis at 
ANC (P < 0.001) were found to be independent predictors 
of HIV seroconversion among pregnant women delivering 
at BMC. All pregnant women who seroconverted attended 
their initial ANC outside BMC and self-reported that the HIV 
serostatus of their husbands was unknown [Table 2].
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This study showed that pregnant women who are unmarried, 
women in a polygamous marriage, women living in a separate 
house from husbands and women married to frequently 
traveling husbands were more likely to seroconvert. Other 
similar studies have also shown that single mothers,[7] 
polygamous relationship and multiple sexual partners.[6,12,17] 
are potential risk factors for HIV seroconversion among 
pregnant women. Polygamy reduces family cohesion thus 
increasing the possibility of women to have other partners 
and infection of any of the partners in the network puts 
everyone else at risk of acquiring HIV.[6,12] Pregnant women 
at the peak of reproductive age (25–30 years) in the present 
study were more likely to seroconvert (7.2%), although 
the	difference	was	not	statistically	significant	(P = 0.09), 
other similar study showed the difference to be statistical 
significant	(15–34	years, P < 0.005).[7] Suggesting that this 
age range may be associated with higher sexual activities. 
Similar to other studies,[6,15] high seroconversion rate was 
shown among pregnant women married to mobile husbands. 
This can be explained by the fact that women married 
to mobile husbands can engage in casual partnerships 
because they are either free, lonely or experience economic 
hardship.[6,15] It is well-known that ulcerative sexual 
transmitted infections facilitates HIV transmission.[18] 
and similar to other studies,[4,6] the present study has also 
shown that pregnant women with a history of syphilis were 
significantly	prone	to	seroconvert	(P < 0.001). This study 
found that all HIV seroconverted pregnant women reported 
that the HIV serostatus of their husbands was unknown. 
This can be explained by the fact that in Tanzania the 
policy on HIV screening among pregnant women’s partners 
is not stringently implemented and as a matter of fact no 
commitment of these partners to attend ANC clinics. A study 
conducted in Iringa, Tanzania has shown that HIV testing 
aimed at prevention of horizontal and vertical transmission 
of HIV during pregnancy require communication and 
support within the couple.[19] Furthermore, involvement 
of the local community can increase the number of male 
partners tested annually from 7% to 50%.[19] and thus, 
uncovering male partners HIV serostatus in the context of 
prevention of maternal to child transmission of HIV.
Upon assessment of the possibility of HIV transmission 
from HIV seroconverted women to their babies, our study 
revealed	 unfortunately	 that	 one	 baby	was	 confirmed	 to	
be HIV infected despite the antiretroviral therapy (ART) 
prophylaxis intervention given to all mothers and their 
babies as per Tanzanian NACP guidelines.[9]	This	finding	
is low compared to the previous study done in Thailand 
where 13.3% (2/15) of the infants born to women who 
seroconverted were infected.[20] The low infection rate 
in Tanzania compared to Thailand could be attributed to 
the ART prophylaxis intervention given to the mother at 
the onset of labor and for the baby after deliver, which is 
routinely done in Tanzania.
Table 1: Social, demographic, and obstetric 































Mother  to  ch i ld  t ransmi s s ion  o f  human 
immunodeficiency virus
One of the 21 babies (4.8%) born of HIV seroconverted women 
was	confirmed	to	be	HIV	infected.
Discussion
Human	 immunodeficiency	 virus	 seroconversion	 among	
pregnant women in this study (5.3%) is higher than 1.02% 
reported in Namibia[8] and 2.6% in Kenya,[12] but lower 
that 17.7% reported in Zimbabwe.[15] indicating that HIV 
is still a public health problem among pregnant women 
in both countries, but the magnitude of problem varies 
from	country	to	country	reflecting	different	interventional	
policies to combat HIV infection in these countries. 
However, basing on the HIV detection methods (i.e. rapid 
HIV serological methods) used in the present study, the 
magnitude could have been higher if the ultra-sensitive 
methods (i.e. HIV DNA/RNA methods) were to be 
employed. This emphasizes the need to introduce the later 
methods to timely uncover the incident HIV infections 
antenatally as shown in developed countries though cost 
remains a challenge.[5]
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Limitations
This study used rapid HIV serological tests, which could not 
detect the women who were in the window period. Thus, 
the later may have been missed and as a result, the actual 
seroconversion may be higher than what is reported here. 
Molecular based HIV DNA/RNA detection method would 
have been of interest to address this limitation. Furthermore, 
most women delivering at BMC have underlying obstetric 
risks; thus, information reported here may not be generalized 
to all women of reproductive age in Tanzania.
Conclusion
There is a high rate of HIV seroconversion among 
pregnant women attending BMC for delivery. This missed 
opportunity may go undetected at delivery if re-testing is 
not done, thus emphasizing on HIV re-testing near term or 
during delivery among all pregnancy women who tested 
negative during ANC. This will allow timely provision 
of ART prophylaxis to HIV seroconverted women and 
their exposed babies and thus, prevent mother to child 
transmission of HIV. Polygamous marriage and history 
of syphilis during ANC were found to be independent 
predictors of HIV seroconversion and as a matter of fact 
couple counseling on safe sexual practices as well as active 
screening and treatment of STIs in all pregnant women 
should be an enduring exercise during ANC visits.
Acknowledgments
We extend our sincere gratitude to all pregnant women involved in 
this study. We thank Dr. Benson R. Kidenya and Dr. Fadhili Lyimo 
for their support during data analysis. We are also thankful to Mama 
Minde, Bonifasi and Chaki for their endless technical assistance 
during data collection. This work was funded by Ministry of Health 
and Social Welfare, United Republic of Tanzania to HM.
References
1. UNAIDS Global Report: UNAIDS Report on the Global 
AIDS Epidemic 2013. Joint United Nations Programme on 
HIV/AIDS (UNAIDS); 2013.
2. Shetty AK. Epidemiology of HIV infection in women and 
children: A global perspective. Curr HIV Res 2013;11:81‑92.
3. Habib NA, Daltveit AK, Bergsjø P, Shao J, Oneko O, 
Lie RT. Maternal HIV status and pregnancy outcomes 
in northeastern Tanzania: A registry‑based study. BJOG 
2008;115:616‑24.
4. Imade P, Ibadin K, Eghafona N, Enabulele O, Ophori E. HIV 
seroprevalence among pregnant women attending ante‑natal 
clinic in a tertiary health institution in Benin City, Nigeria. 
Maced J Med Sci 2010;3:43‑5.
Table 2: Risk factors associated with HIV seroconversion among pregnant women
Variable Seroconversion (n (%)) Bivariate Multivariate
Positive Negative OR (95% CI) P OR (95% CI) P
Age
<25 5 (2.9) 169 (97.1) 1
25‑30 10 (7.2) 129 (92.8) 2.6 (0.9‑7.8) 0.09 ‑ ‑
>30 6 (6.9) 81 (93.1) 2.5 (0.7‑8.4) 0.14
Residence
Urban 19 (5.4) 331 (94.6) 1
Rural 2 (4.0) 48 (96.0) 0.7 (0.2‑3.2) 0.50 ‑ ‑
Marital status
Married 16 (4.4) 347 (95.6) 1 1
Unmarried 5 (13.5) 32 (86.5) 3.4 (1.2‑9.9) 0.02 0.9 (0.1‑8.6) 0.98
Marriage type
Monogamy 10 (2.8) 345 (97.2) 1 1
Polygamy 11 (24.4) 34 (75.6) 11.2 (4.4‑28.2) <0.001 31.1 (4.3‑226.7) <0.001
Relationship with husband
Living together 7 (2.4) 288 (97.6) 1 1
Separate house 4 (10.3) 35 (89.7) 4.7 (1.3‑16.9) 0.02 0.3 (0.0‑3.8) 0.37
Mobile husbands 10 (15.2) 56 (84.8) 7.3 (2.7‑20.1) <0.001 2.9 (0.7‑12.3) 0.13
Place of ANC
Bugando 0 (0.0) 8 (100.0) 1 0.65 ‑ ‑
Other RCH** 21 (5.4) 371 (94.6) Omittedǂ
HIV serostatus of husband
Negative 0 (0.0) 206 (100.0) 1 <0.001 ‑ ‑
Unknown 21 (10.8) 173 (89.2) Omittedǂ
History of syphilis at ANC
Negative 14 (3.6) 376 (96.4) 1 1 0.001
Positive 7 (70.0) 3 (30.0) 62.7 (14.6‑268.2) <0.001 67.2 (10.3‑37.3)
**Reproductive and Child Health, ǂThese factors predicted perfectly the outcome. HIV: Human immunodeficiency virus, ANC: Antenatal care, OR: Odds ratio, CI: Confidence interval
Mbena, et al.: HIV seroconversion among pregnant women in Tanzania
Annals of Medical and Health Sciences Research | Sep-Oct 2014 | Vol 4 | Issue 5 | 737
5. Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf L, 
et al. Frequent detection of acute HIV infection in pregnant 
women. AIDS 2007;21:2303‑8.
6. Msuya SE, Mbizvo E, Hussain A, Uriyo J, Sam NE, 
Stray‑Pedersen B. HIV among pregnant women in Moshi 
Tanzania: The role of sexual behavior, male partner 
characteristics and sexually transmitted infections. AIDS Res 
Ther 2006;3:27.
7.	 Buseri	F,	Seiyaboh	E,	Jeremiah	Z.	Surveying	Infections	among	
Pregnant Women in the Niger Delta, Nigeria. J Glob Infect 
Dis 2010;2:203‑11.
8.	 Boly	L,	Ndile	J,	Zwartz	F,	Sabwa	H,	Musyoka	K,	Namukwambi	
R et al. Screening for HIV seroconversion among pregnant 
women in rural Namibia. In: IAS, editor. Rome, Italy: 
International AIDS Society; 2011.
9. NACP. National guidelines for the management of HIV and 
AIDS. Ministry of health of and social welfare. The United 
Republic of Tanzania. 4thed. Dar‑Es‑Salaam: Government of 
Tanzania. 2012.
10. THMIS. Tanzania HIV/AIDS and malaria indicator survey 
2011‑12.	Dar	 es	 Salaam,	Tanzania:	TACAIDS,	ZAC,	NBS,	
OCGS, and ICF International; 2013.
11. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, 
Wabwire‑Mangen F, et al. Increased risk of incident HIV 
during pregnancy in Rakai, Uganda: A prospective study. 
Lancet 2005;366:1182‑8.
12. Kinuthia J, Kiarie JN, Farquhar C, Richardson B, Nduati R, 
Mbori‑Ngacha D, et al. Cofactors for HIV‑1 incidence during 
pregnancy and postpartum period. Curr HIV Res 2010;8:510‑4.
13. Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodríguez D, 
Smith	L.	Acquiring	human	immunodeficiency	virus	during	
pregnancy and mother‑to‑child transmission in New York: 
2002‑2006. Obstet Gynecol 2010;115:1247‑55.
14. Kaldensjö T, Petersson P, Tolf A, Morgan G, Broliden K, 
Hirbod T. Detection of intraepithelial and stromal Langerin 
and CCR5 positive cells in the human endometrium: Potential 
targets for HIV infection. PLoS One 2011;6:e21344.
15. Mbizvo MT, Kasule J, Mahomed K, Nathoo K. HIV‑1 
seroconversion incidence following pregnancy and delivery 
among women seronegative at recruitment in Harare, 
Zimbabwe.	Cent	Afr	J	Med	2001;47:115‑8.
16. Nuwagaba‑Biribonwoha H, Werq‑Semo B, Abdallah A, 
Cunningham A, Gamaliel JG, Mtunga S, et al. Introducing a 
multi‑site program for early diagnosis of HIV infection among 
HIV‑exposed infants in Tanzania. BMC Pediatr 2010;10:44.
17. Mnyika KS, Klepp KI, Kvåle G, Ole‑King’ori N. Risk factors 
for HIV‑1 infection among women in the Arusha region of 
Tanzania.	 J	Acquir	 Immune	Defic	 Syndr	Hum	Retrovirol	
1996;11:484‑91.
18. Fleming DT, Wasserheit JN. From epidemiological synergy 
to public health policy and practice: The contribution of other 
sexually transmitted diseases to sexual transmission of HIV 
infection. Sex Transm Infect 1999;75:3‑17.
19. Kikumbih N, Nielsen‑Bobbit J, Mbandi A, Motta W, Killian R, 
Mwanga, F. Will your partner be attending? Involving men 
in the prevention of mother‑to‑child transmission of HIV in 
antenatal care clinics in Iringa, Tanzania. In: AIDS, editor. 
Washington DC USA: XIX International AIDS Conference; 
2012.
20. Roongpisuthipong A,  Sir iwasin W, Simonds RJ, 
Sangtaweesin V, Vanprapar N, Wasi C, et al. HIV seroconversion 
during pregnancy and risk for mother‑to‑infant transmission. 
J	Acquir	Immune	Defic	Syndr	2001;26:348‑51.
How to cite this article: ???.
Source of Support: Nil. Conflict of Interest: None declared.
